In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: Analysis of mechanisms involved in resistance
- Sara M. Soto,
- ,
- M. Carmen Mendoza,
- Jordi Vila
- University of Oviedo,
- ,
- Hospital Clínic – Universitat de Barcelona
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 537-540 (4 pages)Journal (Volume, Issue Number)
International Journal of Antimicrobial Agents (Volume 22, Issue 5)Publication milestones
- Published - 11/2003
Publication status
ISSN
0924-8579Publication IDs
- Scopus: 0242384669
- PubMed: 14602375
Abstract
This study analysed the mechanisms involved in the acquisition of resistance to quinolones in mutants obtained in vitro of Salmonella enterica serotype Enteritidis. Two nalidixic acid-resistant (minimal inhibitory concentrations, MIC>256 mg/l), ciprofloxacin-susceptible (MIC 0.5 mg/l) clinical isolates of Salmonella Enteritidis with a mutation at amino acid codon Ser-83 of the gyrA gene were grown on plates containing increasing concentrations of ciprofloxacin. The increase in MIC to ciprofloxacin, sparfloxacin and trovafloxacin was totally or partially associated with over-expression of an AcrAB-like efflux pump. In addition, unidentified mechanism(s) may have been involved in the increased MIC to these antimicrobials. This study demonstrated that AcrAB-like efflux pumps appear to play a relevant role in the increase in MIC to some quinolones although, other, as yet undefined, mechanisms may be involved.
Funding Details
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
